ConductScience.org, home

Paper21833767

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.

Ilari A and 7 others. Amino Acids, 2012. Cited by 132 papers, by iCite.

Cite this record

ConductScience Library. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition. Papers, record 21833767. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21833767

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
PubMed
Journal
Amino Acids
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
4.96
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ilari AAndrea
2Baiocco PPaola
3Messori LLuigi
4Fiorillo AAnnarita
5Boffi AAlberto
6Gramiccia MMarina
7Di Muccio TTrentina
8Colotti GGianni

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiprotozoal AgentsMajor topic
AuranofinMajor topic
Biogenic PolyaminesMajor topic
GoldMajor topic
Leishmania infantumMajor topic
NADH, NADPH OxidoreductasesMajor topic
Animals
Models, Molecular
X-Ray Diffraction

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110090783Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.J Med Chem1999https://conductscience.org/library/papers/10090783PubMed
211123991(2,2':6',2"-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase.J Med Chem2000https://conductscience.org/library/papers/11123991PubMed
316565519Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells.J Biol Chem2006https://conductscience.org/library/papers/16565519PubMed
43142020Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis.Rheumatol Int1988https://conductscience.org/library/papers/3142020PubMed
517448941Cutaneous leishmaniasis treatment.Travel Med Infect Dis2007https://conductscience.org/library/papers/17448941PubMed
615572765Coot: model-building tools for molecular graphics.Acta Crystallogr D Biol Crystallogr2004https://conductscience.org/library/papers/15572765PubMed
719710012Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects.J Biol Chem2009https://conductscience.org/library/papers/19710012PubMed
819200044Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.Protein Pept Lett2009https://conductscience.org/library/papers/19200044PubMed
917055060Synthesis and characterization of [Au(dppz)2]Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana.J Inorg Biochem2007https://conductscience.org/library/papers/17055060PubMed
1017640917Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17640917PubMed
1118164763Synthesis and characterization of platinum-sterol hydrazone complexes with biological activity against Leishmania (L.) mexicana.J Inorg Biochem2008https://conductscience.org/library/papers/18164763PubMed
129251892The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines.Gen Pharmacol1997https://conductscience.org/library/papers/9251892PubMed
1316722651Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.J Med Chem2006https://conductscience.org/library/papers/16722651PubMed
149685351Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.J Biol Chem1998https://conductscience.org/library/papers/9685351PubMed
1520127392HIV therapeutic possibilities of gold compounds.Biometals2010https://conductscience.org/library/papers/20127392PubMed
1611749494Gold-based therapeutic agents.Chem Rev1999https://conductscience.org/library/papers/11749494PubMed
1720127591Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug.Cent Eur Neurosurg2010https://conductscience.org/library/papers/20127591PubMed
1915299926Refinement of macromolecular structures by the maximum-likelihood method.Acta Crystallogr D Biol Crystallogr1997https://conductscience.org/library/papers/15299926PubMed
207607216Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials.Eur J Biochem1995https://conductscience.org/library/papers/7607216PubMed
2124900299Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation.ACS Med Chem Lett2011https://conductscience.org/library/papers/24900299PubMed

See all 35 referencesDownload CSV of references

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
42943213In Vitro Antileishmanial Activity and Cytotoxicity Evaluation of 2-(Thiophen-2-ylmethyl)quinazolin-4(3H)-one Derivatives Against Leishmania tropica and Leishmania infantum.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943213PubMed
42802304Beyond the Active Site: First-In-Class Leishmania Infantum Trypanothione Reductase Dimerization Disruptors as Antileishmanial Leads.ChemMedChem2026https://conductscience.org/library/papers/42802304PubMed
42334839Mechanism of auranofin toxicity: Inhibition of tetrahydrobiopterin metabolism.Toxicol Appl Pharmacol2026https://conductscience.org/library/papers/42334839PubMed
42322249Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.Protein Sci2026https://conductscience.org/library/papers/42322249PubMed
41701359Molecular docking: a computational approach for the discovery of novel targets against visceral leishmaniasis.J Mol Model2026https://conductscience.org/library/papers/41701359PubMed
41304874Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304874PubMed
41176922Investigations of gold(I) complexes as inhibitors of caspase-1.J Inorg Biochem2026https://conductscience.org/library/papers/41176922PubMed
40872574Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872574PubMed
40579895Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma.Cancer Biol Med2025https://conductscience.org/library/papers/40579895PubMed
39552640Functional utility of gold complexes with phosphorus donor ligands in biological systems.Coord Chem Rev2025https://conductscience.org/library/papers/39552640PubMed
39421030In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review.EXCLI J2024https://conductscience.org/library/papers/39421030PubMed
394075831,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum Target Proteins.Molecules2024https://conductscience.org/library/papers/39407583PubMed
39001837Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials.ACS Infect Dis2024https://conductscience.org/library/papers/39001837PubMed
38792079Targeting Trypanothione Metabolism in Trypanosomatids.Molecules2024https://conductscience.org/library/papers/38792079PubMed
38675113Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents.Pharmaceutics2024https://conductscience.org/library/papers/38675113PubMed
38244050Study of metalation of thioredoxin by gold(I) therapeutic compounds using combined liquid chromatography/capillary electrophoresis with inductively coupled plasma/electrospray MS/MS detection.Anal Bioanal Chem2024https://conductscience.org/library/papers/38244050PubMed
38206030Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin.Microbiol Spectr2024https://conductscience.org/library/papers/38206030PubMed
38009165Triethyl phosphine decorated cerium oxide nanoparticles exhibit selective killing of the unicellular protozoan parasite Leishmania donovani.3 Biotech2023https://conductscience.org/library/papers/38009165PubMed
37631260Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as Leishmania mexicana Inhibitors.Pharmaceutics2023https://conductscience.org/library/papers/37631260PubMed
37333656Novel gold(III)-dithiocarbamate complex targeting bacterial thioredoxin reductase: antimicrobial activity, synergy, toxicity, and mechanistic insights.Front Microbiol2023https://conductscience.org/library/papers/37333656PubMed

See all 69 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F2R2149PubTator's text mininghttps://conductscience.org/library/genes/2149NCBI Gene
TXNRD3114112PubTator's text mininghttps://conductscience.org/library/genes/114112NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21833767

GET https://conductscience.org/api/papers/v1/21833767/references?page=2